Annual Total Debt
$229.19 M
+$31.13 M+15.72%
31 December 2023
Summary:
Xeris Biopharma Holdings annual total debt is currently $229.19 million, with the most recent change of +$31.13 million (+15.72%) on 31 December 2023. During the last 3 years, it has risen by +$142.17 million (+163.37%). XERS annual total debt is now at all-time high.XERS Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$270.96 M
+$1.16 M+0.43%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly total debt is currently $270.96 million, with the most recent change of +$1.16 million (+0.43%) on 30 September 2024. Over the past year, it has increased by +$43.02 million (+18.87%). XERS quarterly total debt is now -97.48% below its all-time high of $10.76 billion, reached on 31 December 2017.XERS Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.7% | +18.9% |
| 3 y3 years | +163.4% | +208.9% |
| 5 y5 years | +618.7% | +366.2% |
XERS Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +163.4% | at high | +208.9% |
| 5 y | 5 years | at high | +618.7% | at high | +366.2% |
| alltime | all time | at high | -97.5% |
Xeris Biopharma Holdings Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $270.96 M(+0.4%) |
| June 2024 | - | $269.80 M(+0.4%) |
| Mar 2024 | - | $268.69 M(+17.2%) |
| Dec 2023 | $229.19 M(+15.7%) | $229.19 M(+0.5%) |
| Sept 2023 | - | $227.94 M(+1.3%) |
| June 2023 | - | $224.99 M(+13.4%) |
| Mar 2023 | - | $198.42 M(+0.2%) |
| Dec 2022 | $198.06 M(+124.9%) | $198.06 M(+43.0%) |
| Sept 2022 | - | $138.51 M(+0.3%) |
| June 2022 | - | $138.07 M(+0.1%) |
| Mar 2022 | - | $137.98 M(+56.7%) |
| Dec 2021 | $88.07 M(+1.2%) | $88.07 M(+0.4%) |
| Sept 2021 | - | $87.71 M(+0.3%) |
| June 2021 | - | $87.48 M(+0.2%) |
| Mar 2021 | - | $87.27 M(+0.3%) |
| Dec 2020 | $87.02 M | $87.02 M(-27.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $119.39 M(+9.1%) |
| June 2020 | - | $109.48 M(+87.2%) |
| Mar 2020 | - | $58.48 M(+0.3%) |
| Dec 2019 | $58.30 M(+82.8%) | $58.30 M(+0.3%) |
| Sept 2019 | - | $58.12 M(+79.4%) |
| June 2019 | - | $32.40 M(-98.8%) |
| Mar 2019 | - | $2.62 B(+18.0%) |
| Dec 2018 | $31.89 M(>+9900.0%) | $2.22 B(-28.8%) |
| Sept 2018 | - | $3.11 B(+0.1%) |
| June 2018 | - | $3.11 B(-9.8%) |
| Mar 2018 | - | $3.45 B(-67.9%) |
| Dec 2017 | $0.00(0.0%) | $10.76 B(>+9900.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00 |
| Dec 2016 | $0.00 | - |
FAQ
- What is Xeris Biopharma Holdings annual total debt?
- What is the all time high annual total debt for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual total debt year-on-year change?
- What is Xeris Biopharma Holdings quarterly total debt?
- What is the all time high quarterly total debt for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly total debt year-on-year change?
What is Xeris Biopharma Holdings annual total debt?
The current annual total debt of XERS is $229.19 M
What is the all time high annual total debt for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual total debt is $229.19 M
What is Xeris Biopharma Holdings annual total debt year-on-year change?
Over the past year, XERS annual total debt has changed by +$31.13 M (+15.72%)
What is Xeris Biopharma Holdings quarterly total debt?
The current quarterly total debt of XERS is $270.96 M
What is the all time high quarterly total debt for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly total debt is $10.76 B
What is Xeris Biopharma Holdings quarterly total debt year-on-year change?
Over the past year, XERS quarterly total debt has changed by +$43.02 M (+18.87%)